Trial Profile
A Phase 1 Pharmacokinetic/Pharmacodynamic Study of Oral Beclomethasone 17,21-Dipropionate (BDP) in Healthy Adolescents and Young Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Jul 2013
Price :
$35
*
At a glance
- Drugs Beclometasone (Primary)
- Indications Crohn's disease
- Focus Pharmacodynamics; Pharmacokinetics
- 28 Jun 2013 Results have been reported briefly in a Soligenix media release.
- 28 Jun 2013 Status changed from recruiting to completed, according to a Soligenix media release.
- 16 May 2013 Status changed from not yet recruiting to recruiting, as reportd by a Soligenix media release.